Acknowledgments
The National Biospecimen Network (NBN) Blueprint could not have been completed without the
generous assistance of more than 100 participants who willingly volunteered their expertise and
insights. In addition to those who participated in discussions on the integration of the document
at the NBN Design Team and Advisors Meeting in Bethesda, MD (Appendix F), the following
experts contributed substantively to this document: Lucille L. Adams-Campbell, Jules Berman,
Col. Kenneth Bertram, Marianna Bledsoe, Andrea Califano, José Costa, Martin Ferguson, David
Fitzgerald, Michael Katz, David Kerr, Kim Lyerly, Mary McCabe, Mark McGrath, Alan Rabson,
Cathy Ratcliffe, and Sheila Taube. Special thanks are due in particular to Roger Aamodt, Alan
Buckler, Dan Crichton, William Grizzle, and Julie Kaneshiro for their detailed comments on
earlier drafts of the Blueprint. Donna Bonner, Ellen Eisner, Nina Ghanem, Charles Goldwaithe,
Nina Goodman, Donald Johnsey, David Korn, Jo-Ann Kriebel, Carl Roth, Karl Schwartz, Sudhir
Srivastava, and Jim Vaught also provided helpful input.
Funding for the development and production of this report was provided by the National
Dialogue on Cancer (NDC) and the National Cancer Institute (NCI). The support from Anna D.
Barker, Connie R. Curran, Allan Erickson, Matt Mangan, Mark Mendenhall, Hal Moses, and
Andrew von Eschenbach, affiliates of the NDC, is gratefully acknowledged. Special
acknowledgements are extended to Anna D. Barker, Kenneth Buetow, Gregory Downing, Julie
Schneider, and Andrew von Eschenbach with the NCI for their extraordinary dedication and
expert direction throughout the NBN Blueprint development process, and to Travis Earles and
Tracey Nathaniel for their administrative assistance.
Special thanks go to the Constella Health Sciences staff who served as module coordinators and
lead science writers: Andrew Friede, Ruth Grossman, Rachel Hunt, Rose Maria Li, and Susan
Stern. Other Constella Health Sciences staff who assumed responsibilities for editing, document
formatting, graphics, meeting planning, and management are gratefully acknowledged for their
contributions: Beverly-Jean Cambridge, Mary Cadette, Patti Collins, Mary Conley, Bruce
Dennis, Patricia Downey, Anne Fabiszewski, Kerry Groome, Ann Hennigan, Chris LeGrand,
Tracy Lyles, Elisa Madonna, Keith Maynard, Julie McLaughlin, Harry Milman, Bonnie Ortiz,
Alecia Saah, Jennifer Solomon, Diane Stidham, Ann Thompson, Thomas Timmons, and Louise
Wides.
Finally, we wish to recognize the tremendous efforts of cancer advocacy groups for their
invaluable participation in the fight to cure and prevent cancer.
|
